Search

Your search keyword '"Falzon, Mary"' showing total 262 results

Search Constraints

Start Over You searched for: Author "Falzon, Mary" Remove constraint Author: "Falzon, Mary"
262 results on '"Falzon, Mary"'

Search Results

1. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

2. The evolution of non-small cell lung cancer metastases in TRACERx

3. The evolution of lung cancer and impact of subclonal selection in TRACERx

4. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer : TARGIT-A randomised clinical trial

5. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer

6. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

7. HER2 testing

8. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

9. Breast Cancer

10. HER2 Testing

11. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

12. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

13. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

14. Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

15. Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

16. Supplementary Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

17. Body composition and lung cancer-associated cachexia in TRACERx

18. The evolution of lung cancer and impact of subclonal selection in TRACERx

19. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

21. Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways

22. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

23. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

24. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

26. Abstract PR002: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

27. Abstract A012: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

29. Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

31. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

33. Research in progress—LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group

34. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

36. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

37. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

38. LUNG CANCER EVOLUTION: Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

41. Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma

42. Handbook of HER2-targeted agents in breast cancer

43. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development

45. List of Contributors

50. Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

Catalog

Books, media, physical & digital resources